Nature-inspired peptide technology that prevents biofilm formation across desalination, cooling towers, maritime and industrial systems.
In a wet environment
Single cell organisms settle on hard surfaces in water
Microbes form a slime layer that aids surface attachment and survival
Other organisms, plants and algae attach to biofilms, grow and create a community
Biofilm and Biofouling
costs global industries
over $100B annually.
+20% energy consumption
Increased operational costs
Frequent cleaning
Membrane replacement
Equipment damage
Toxic chemicals
Anti-microbial resistance
Regulatory pressure
We Mimic Nature’s 600M-Year Biofilm Defense.
Also about IP peptide protected technology.
Sea anemone
Triggers microbial dispersion, preventing and treating biofilm
Engineered, stable peptide replicating the signaling function that is non-toxic.
Solving Biofilm in Pipes, Desalination Plants, Cooling Towers, and Industrial Water Systems
Partial, inconsistent
effectiveness
Protects a mid-size SWRO for one year
Protects an entire container ship
Water dosing
Paint & coating additive
Scalable synthesis ready
No infrastructure or
workflow changes
in biofilm on desalination membranes over a 20-day trial
electricity use related to biofilm management through reduced pressure
Over traditional chlorine treatments in desalination plants
Annual fuel savings potential per large vessel for maritime applications
2 pilots planned
Singapore & Israel
Started with a global
partner – 2 labs testing
Started a 2-phase navy
test (sticky peptide)
DisperseBio engineers protein-based solutions for one of industry’s oldest and most costly challenges: biofilm, a problem estimated to cost over $100 billion annually.
Our peptide platform is built on years of research into how marine organisms naturally control microbial communities – without killing them.
We replace toxic anti-foulants with biology that is safer, smarter, more sustainable, and cost-effective. By targeting the signals that drive biofilm formation, our technology prevents fouling before it starts, reducing chemical use while improving operational performance.
We believe the future of industrial protection lies in working with nature, not against it.








Serial entrepreneur and investor with a track record of building and scaling deep-tech ventures. Formerly led VLX Ventures, with senior business development roles at SanDisk, M-Systems, and Orange. Brings strong expertise in commercialization, partnerships, and taking technologies from concept to market in heavy regulated markets.
Microbiologist and inventor of DisperseBio’s technology. Led Infectious Disease Research at Sheba Medical Center and served as CSO at Hutchinson Water, pivoting clinical expertise into water treatment innovation.
CFO with 20+ years of experience leading financial strategy, operations, and execution across startups and global companies. Extensive experience in IPO readiness, M&A, and venture capital, with deep expertise in DeepTech and MedTech, enabling scalable growth and disciplined financial management.
© 2026 DisperseBio. All rights reserved. Privacy Policy.
Fill out the form below, and we will be in touch shortly.